A review of the use of melatonin in ulcerative colitis: Experimental evidence and new approaches

Inflammatory Bowel Diseases

Volumn 20, Issue 3, 2014, Pages 553-563

  Jena, Gopabandhu ^a   Trivedi, Priyanka P ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

DNA damage; Inflammation; Melatonin; Novel targets; Oxidative stress; Ulcerative colitis

Indexed keywords

DEATH RECEPTOR; INTERLEUKIN 17; MELATONIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; SIRTUIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR NRF2;

DISEASE COURSE; DISEASE SEVERITY; DNA DAMAGE; EPIGENETICS; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; TELOMERE; ULCERATIVE COLITIS;

ANIMALS; ANTIOXIDANTS; COLITIS, ULCERATIVE; HUMANS; MELATONIN;

EID: 84898740707     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000436962.32164.6e     Document Type: Review

References (48)

1. Reiter RJ, Tan DX, Rosales-Corral S, et al. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem. 2013;13:373-384.
2. Stehle JH, Saade A, Rawashdeh O, et al. A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res. 2011;51:17-43.
3. Lerner AB, Case JD, Takahashi Y, et al. Isolation of melatonin, the pineal gland factor that lightens melanocyteS1. J Am Chem Soc. 1958; 80:2587-2587.
4. Raikhlin NT, Kvetnoi IM. Biological identification of melatonin in enterochromaffin cells [in Russian]. Dokl Akad Nauk SSSR. 1974;215: 731-732.
5. Bubenik GA, Brown GM, Grota LJ. Immunohistological localization of melatonin in the rat digestive system. Experientia. 1977;33:662-663.
6. Huether G. The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia. 1993; 49:665-670.
7. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci. 2002;47:2336-2348.
8. Chen CQ, Fichna J, Bashashati M, et al. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol. 2011;17:3888-3898.
9. Motilva V, Garcia-Maurino S, Talero E, et al. New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin. J Pineal Res. 2011;51:44-60.
10. Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res. 2011;51:1-16.
11. Galano A, Tan DX, Reiter RJ. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res. 2013;54:245-257.
12. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine. 2005;27:119-130.
13. Mauriz JL, Collado PS, Veneroso C, et al. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res. 2013;54:1-14.
14. Proietti S, Cucina A, Reiter RJ, et al. Molecular mechanisms of melatonin's inhibitory actions on breast cancers. Cell Mol Life Sci. 2013;70: 2139-2157.
15. Reiter RJ, Paredes SD, Manchester LC, et al. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol. 2009;44:175-200.
16. Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J. 1993;1:57-60.
17. Arguelles S, Munoz MF, Cano M, et al. In vitro and in vivo protection by melatonin against the decline of elongation factor-2 caused by lipid peroxidation: preservation of protein synthesis. J Pineal Res. 2012;53:1-10.
18. Laliena A, San Miguel B, Crespo I, et al. Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin. J Pineal Res. 2012;53:270-278.
19. Song N, Kim AJ, Kim HJ, et al. Melatonin suppresses doxorubicininduced premature senescence of A549 lung cancer cells by ameliorating mitochondrial dysfunction. J Pineal Res. 2012;53:335-343.
20. Abe M, Reiter RJ, Orhii PB, et al. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res. 1994;17:94-100.
21. Cardinali DP, Srinivasan V, Brzezinski A, et al. Melatonin and its analogs in insomnia and depression. J Pineal Res. 2012;52:365-375.
22. de Matos Cavalcante AG, de Bruin PF, de Bruin VM, et al. Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study. J Pineal Res. 2012;53:238-244.
23. Gitto E, Pellegrino S, Gitto P, et al. Oxidative stress of the newborn in the pre-and postnatal period and the clinical utility of melatonin. J Pineal Res. 2009;46:128-139.
24. Koppisetti S, Jenigiri B, Terron MP, et al. Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review. Dig Dis Sci. 2008;53:2592-2603.
25. Kotlarczyk MP, Lassila HC, O'Neil CK, et al. Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res. 2012;52:414-426.
26. Maldonado MD, Murillo-Cabezas F, Terron MP, et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res. 2007;42:1-11.
27. Peschke E, Hofmann K, Ponicke K, et al. Catecholamines are the key for explaining the biological relevance of insulin-melatonin antagonisms in type 1 and type 2 diabetes. J Pineal Res. 2012;52:389-396.
28. Rosales-Corral SA, Acuna-Castroviejo D, Coto-Montes A, et al. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin. J Pineal Res. 2012;52:167-202.
29. Santhi N, Thorne HC, van der Veen DR, et al. The spectral composition of evening light and individual differences in the suppression of melatonin and delay of sleep in humans. J Pineal Res. 2012;53:47-59.
30. Konturek PC, Brzozowska I, Targosz A, et al. Esophagoprotection mediated by exogenous and endogenous melatonin in an experimental model of reflux esophagitis. J Pineal Res. 2013;55:46-57.
31. Mozaffari S, Rahimi R, Abdollahi M. Implications of melatonin therapy in irritable bowel syndrome: a systematic review. Curr Pharm Des. 2010;16:3646-3655.
32. Rakhimova O. Use of melatonin in combined treatment for inflammatory bowel diseases [in Russian]. Ter Arkh. 2010;82:64-68.
33. Werbach MR. Melatonin for the treatment of gastroesophageal reflux disease. Altern Ther Health Med. 2008;14:54-58.
34. Tahan G, Gramignoli R, Marongiu F, et al. Melatonin expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic-acid-induced colitis in rats. Dig Dis Sci. 2011;56:715-720.
35. Okada Y, Tsuzuki Y, Miyazaki J, et al. Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut. 2006;55:681-688.
36. Rosillo MA, Sanchez-Hidalgo M, Cardeno A, et al. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol Res. 2012;66:235-242.
37. Trivedi PP, Jena GB. Dextran sulfate sodium-induced ulcerative colitis leads to increased hematopoiesis and induces both local as well as systemic genotoxicity in mice. Mutat Res. 2012;744:172-183.
38. Yao J, Wang JY, Liu L, et al. Anti-oxidant effects of resveratrol on mice with DSS-induced ulcerative colitis. Arch Med Res. 2010;41:288-294.
39. Bitiren M, Karakilcik AZ, Zerin M, et al. Protective effects of selenium and vitamin E combination on experimental colitis in blood plasma and colon of rats. Biol Trace Elem Res. 2010;136:87-95.
40. Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitisassociated colorectal cancer. Nat Rev Immunol. 2011;11:9-20.
41. Trivedi PP, Jena GB. Ulcerative colitis-induced hepatic damage in mice: studies on inflammation, fibrosis, oxidative DNA damage and GST-P expression. Chem Biol Interact. 2013;201:19-30.
42. Westbrook AM, Wei B, Braun J, et al. Intestinal inflammation induces genotoxicity to extraintestinal tissues and cell types in mice. Int J Cancer. 2011;129:1815-1825.
43. Dong WG, Mei Q, Yu JP, et al. Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis. World J Gastroenterol. 2003; 9:1307-1311.
44. Marquez E, Sanchez-Fidalgo S, Calvo JR, et al. Acutely administered melatonin is beneficial while chronic melatonin treatment aggravates the evolution of TNBS-induced colitis. J Pineal Res. 2006;40:48-55.
45. Aggarwal BB, Sethi G, Ahn KS, et al. Targeting signal-transducer- andactivator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 2006;1091:151-169.
46. Aggarwal BB, Shishodia S, Sandur SK, et al. Inflammation and cancer: how hot is the link? Biochem Pharmacol. 2006;72:1605-1621.
47. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71-78.
48. Ohshima H, Tatemichi M, Sawa T. Chemical basis of inflammationinduced carcinogenesis. Arch Biochem Biophys. 2003;417:3-11.